Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript

Celyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call Transcript March 24, 2023

Operator: Greetings. Welcome to the Celyad Oncology Full-Year 2022 Financial Results. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. . Please note that this conference is being recorded. At this time, I will now like to turn the conference over to David Georges, Vice President of Finance and Administration. David, you may now...